INTRODUCTION
Immunodeficiency syndromes are a heterogeneous group of diseases (1)1 which are characterized by impairment of humoral immunity, cellular immunity, or both. Most patients with impaired humoral immunity appear to make feeble antibody responses, but relatively few patients have been studied systematically (2) (3) (4) (5) (6) (7) (8) (9) .
Received for publication 3 May 1971 . ' The terminology of immunodeficiency diseases used in this paper is that recommended by a working party of the World Health Organization (1) . Terms likely to cause confusion are:
New name
Old name Infantile X-linked Bruton's agammaglobulinemia agammaglobulinemia X-linked immunodeficiency Dysgammaglobulinemia type I with hyper-IgM Severe combined Swiss-type agammaglobuimmunodeficiency linemia, thymic alymphoplasia, thymic dysplasia Bacteriophage OX 174 is a remarkably useful agent for studies of humoral immunity (10) . It is a potent antigen and causes no recognized toxic effects in man (7) . After intravenous administration, phage can be detected easily and enumerated in the blood by plaque count. Thus antigen clearance from the circulation can be determined. Phage neutralization is a sensitive assay for antibody and does not seem selective for one class of immunoglobulin.
The purpose of this report is to present results of studies with bacteriophage OX 174 in various immunodeficiency diseases. 26 patients were immunized with bacteriophage OX 174. Their antigen clearance, primary and secondary antibody response, and the sequence of antibody class, were determined and compared with normal adult volunteers. METHODS Subjects. 5 healthy, young adult volunteers and 26 patients with a variety of immunodeficiency diseases were studied after informed consent was obtained. The clinical and laboratory findings of these patients are characterized in Table I . Methods for studies summarized in Table I have been published (11) (12) (13) . Some of these cases have been reported in part previously; references are cited in the Table. For convenience in presentation, the 26 patients are divided into four groups. Group I consists of eight patients with infantile X-linked agammaglobulinemia. Group II represents eight patients with antibody deficiency syndromes other than the infantile X-linked type. Group III is made up of five patients with ataxia telangiectasia, and group IV consists of five patients with antibody deficiency and gastrointestinal disease.
Bacteriophage OX 174. The phage was grown, harvested, and purified by the method described by Uhr, Finkelstein, and Baumann (10) . The purified phage was sterilized by passage through a 0.45 As micropore filter. Sterilized phage did not cause fever or leukopenia in rabbits. Final preparations of the bacteriophage, containing between 5 X 10"' and 5 X 101 plaque-forming units (PFU)/ml, were stored in small portions at -60'C until thawed for use. There was little decline in phage titer after storage for 6 months.
Phage clearance studies. Phage was given intravenously in a dose of 1. Neutralizing antibody. After phage had disappeared from the circulation, the antibody activity was determined by phage neutralization and was expressed as the rate of inactivation or K value as derived by a standard formula (7) . The lower limit of sensitivity by the usual 1-hr incubation is a K value of 0.01. Saliva and sputum. Saliva specimens were collected from a few volunteers and selected patients after stimulation of salivary flow by chewing sour candy. Sputum was collected from case 18 during postural drainage and pulmonary therapy. The sputum specimens obtained from that case were not grossly blood tinged and had negative tests for hemoglobin.
Gel filtration. Serum and saliva proteins were separated by gel filtration on a 2.5 X 100 cm column of Sephadex G-200 (Pharmacia, Uppsala, Sweden). Sephadex G-200 was sieved (100, 200, and 220 meshes per in.), and middlesized beads were used. The gel was expanded by repeated suspension in boiling water. The buffer for all studies was 0.1 M Tris in 0.15 M NaCl, pH 7.5. The column was adapted for upward flow using an LKB pump (LKB Produkter AB, Stockholm, Sweden) at a rate of 15 ml/hr. Fractions were collected in 6-ml portions. Protein was determined by optical density at 280 X in a Beckman spectrophotometer, and antibody activity was assayed by phage neutralization.
Antibody susceptibility to reducing agents. Susceptibility of phage antibody to 2-mercaptoethanol was done by the method of Grubb and Swahn (15) .
RESULTS
Antigen clearance. Bacteriophage disappeared from the circulation of all volunteers and most patients by the 4th day. This finding is similar to that reported previously (7) . The eight cases classified as infantile X-linked agammaglobulinemia in group I had prolonged circulation of bacteriophage (Fig. 1) . All had bacteriophage present in the circulation for 11 days or more. In most instances the decline in titer of bacteriophage was comparable with the rate of spontaneous inactivation of bacteriophage at 370C. None of the other 18 patients in the study had phage present in the serum 7 days after injection. Case 5 had phage present in his circulation 11 days after injection and none at 18 days. Phage was injected two additional times, and the clearance on both occasions was similar. This patient had a somewhat accelerated clearance of bacteriophage when compared with the other seven cases of X-linked agammaglobulinemics, but the rate of clearance was nevertheless distinctly prolonged as compared with normals or other patient groups.
Antibody response. The range of primary antibody responses to bacteriophage in five healthy adult volunteers is shown by the crosshatched area in Fig. 2 . The K values shown are similar to those obtained in a previous study on six immunologically competent children (7) . Highest K values were consistently reached 2 wk after immunization; titers then declined.
No antibody was detectable in the serum of any of the patients in group I after phage had disappeared from the circulation (K < 0.01). Primary antibody responses of the remaining 18 cases are shown in Fig. 2 (Fig. 4) .
Gel filtration of antibody. At least one specimen obtained from all patients after secondary immunization was studied by gel filtration. The first protein peak in eluates from about half of the volunteers and patients was treated with 2-mercaptoethanol. Antibody activity was completely abolished in every specimen tested, and this procedure was then discontinued. Antibody activity found in the first protein peak will be referred to as IgM, and antibody activity in the second peak will be referred to as IgG.
All volunteers had only IgM antibody at 1 wk after primary immunization (Fig. 6) Antibody activity in saliva. Simultaneously obtained specimens of saliva and serum from the five normal volunteers and eight patients were studied for antibody activity using gel filtration. Antibody of both IgM and IgG mobility was found in saliva. In every instance the antibody in saliva eluted in the same position as that found in the serum. Salivary antibody levels, however, never approached those of serum when compared on the basis of protein concentration. DISCUSSION Antibody activity in this study was calculated from the rate of phage inactivation or K value (7, 10) . This method of assay is based on the assumption that phage neutralization is a first-order reaction (14) , an assumption now known to be incorrect. Because phage neutralization departs from first-order kinetics after 90% or more of the phage has been neutralized, two new methods of calculating antibody activity have been developed (16, 17) . The K value method has greater convenience and simplicity. Our study is primarily concerned with large differences in antibody concentrations, and the results would not be changed significantly by using other methods of calculation. (25, 26) , and L-aspariginase (27) have been shown to suppress the IgG antibody response to a much greater extent than the IgM antibody response. In adult rabbits, 6-mercaptopurine impairs mainly the IgG response; in young rabbits, however, both IgG and IgM antibody responses are suppressed (28) . Some treated animals became completely agammaglobulinemic and made no antibodies. Two theories of the differentiation of antibody-producing cells can account for observations made in experimental animals and in our patients. If different immunoglobulins are produced in separate cell lines (29) , then the IgM-producing cell line must be more resistant to insult. In a more attractive hypothesis, Cain, Cooper, Van Alten, and Good (30) proposed that cells producing all classes of immunoglobulins are products of the same cell line at different stages of differentiation. A stem cell produces first IgM cells and then differentiates into IgG-and IgA-producing cells. Interruption of this sequence at different steps would produce many of the currently recognized antibody deficiencies that are seen in the animal models and in human immunodeficiency diseases. 
